What did we learn from the Global Prevalence studies on Infection in Urology (GPIU)?
dc.authorwosid | Naber, Kurt/AAR-9997-2020 | |
dc.contributor.author | Johansen, T. E. Bjerklund | |
dc.contributor.author | Grabe, M. | |
dc.contributor.author | Tandogdu, Z. | |
dc.contributor.author | Tenke, P. | |
dc.contributor.author | van Ostrum, E. | |
dc.contributor.author | Naber, K. G. | |
dc.contributor.author | Wagenlehner, F. M. E. | |
dc.date.accessioned | 2024-06-12T11:23:56Z | |
dc.date.available | 2024-06-12T11:23:56Z | |
dc.date.issued | 2013 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description | 28th International Congress of Chemotherapy and Infection Incorporating / 14th Asia-Pacific Congress of Clinical Microbiology and Infection -- JUN 05-08, 2013 -- Yokohama, JAPAN | en_US |
dc.description.abstract | [Abstract Not Available] | en_US |
dc.description.sponsorship | Int Soc Chemotherapy | en_US |
dc.identifier.endpage | S34 | en_US |
dc.identifier.issn | 0924-8579 | |
dc.identifier.startpage | S33 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/26730 | |
dc.identifier.volume | 42 | en_US |
dc.identifier.wos | WOS:000321447400105 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Science Bv | en_US |
dc.relation.ispartof | International Journal Of Antimicrobial Agents | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | [No Keywords] | en_US |
dc.title | What did we learn from the Global Prevalence studies on Infection in Urology (GPIU)? | en_US |
dc.type | Conference Object | en_US |